NEU neuren pharmaceuticals limited

that a risk with any clinical stage bio - any biotech will tank...

  1. 657 Posts.
    lightbulb Created with Sketch.  32
    that a risk with any clinical stage bio - any biotech will tank big time if any trial stage fails. Its up to the purchaser/partner to make a calculated risk on the price they are willing to pay based on clinical stage, IP, chance of success, end markets size etc.

    Big pharma need new molecules and they cant just wait for every junior bio to pass P3 and NDA then swoop in. NEU is no different to any other junior bio.

    regarding your casino analogy.... well dunno how to even answer that . I guess people like Merck are throwing 500mill at VLA as they cant carry that much cash into the casino.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Last
$16.66
Change
-0.340(2.00%)
Mkt cap ! $2.147B
Open High Low Volume
$16.99 $17.20 $16.53 524.7K

Buyers (Bids)

Vol. Price($)
1607 $16.64
 

Sellers (Offers)

Price($) Vol.
$16.75 2000
Last trade - 16.25pm 03/07/2026 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.